These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 11888714)
1. Methadone for refractory cancer pain. Shaiova L; Sperber KT; Hord ED J Pain Symptom Manage; 2002 Mar; 23(3):178-80. PubMed ID: 11888714 [No Abstract] [Full Text] [Related]
2. Methadone in treatment of tenesmus not responding to morphine escalation. Mercadante S; Fulfaro F; Dabbene M Support Care Cancer; 2001 Mar; 9(2):129-30. PubMed ID: 11305071 [TBL] [Abstract][Full Text] [Related]
3. Methadone for cancer pain: what have we learned from clinical studies? Soares LG Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785 [TBL] [Abstract][Full Text] [Related]
4. Switching from methadone to tapentadol for cancer pain. Mercadante S; Ferrera P; Adile C J Pain Symptom Manage; 2012 Sep; 44(3):e3-5. PubMed ID: 22819437 [No Abstract] [Full Text] [Related]
5. Very-high-dose methadone with minimal toxicity and inadequate pain control in a hospice patient with cancer. Latuga NM; Wahler RG J Pain Palliat Care Pharmacother; 2013 Jun; 27(2):143-9. PubMed ID: 23646910 [TBL] [Abstract][Full Text] [Related]
7. Pain management in patients with advanced cancer. Berland D Ann Intern Med; 2000 Apr; 132(7):593. PubMed ID: 10744602 [No Abstract] [Full Text] [Related]
8. Methadone use in cancer patients with pain: a review. Bruera E; Sweeney C J Palliat Med; 2002 Feb; 5(1):127-38. PubMed ID: 11839235 [TBL] [Abstract][Full Text] [Related]
9. [Use of methadone in the elderly with cancer pain: a systematic review]. Taberna M; Villavicencio-Chávez C; González-Barboteo J Rev Esp Geriatr Gerontol; 2014; 49(3):129-36. PubMed ID: 24457178 [TBL] [Abstract][Full Text] [Related]
10. The merits of methadone. McCaffery M; Pasero C Am J Nurs; 2000 Jul; 100(7):22-3. PubMed ID: 10914063 [No Abstract] [Full Text] [Related]
11. Methadone: an effective alternative to morphine for pain relief in cancer patients. Shelton BW; Deynes-Romero J; Tofani-Montalvo M; Ramírez-Rivera J; Jaumne-Anselmi F Bol Asoc Med P R; 2008; 100(3):7-10. PubMed ID: 19227708 [TBL] [Abstract][Full Text] [Related]
12. Methadone for cancer-related neuropathic pain: a review of the literature. Mannino R; Coyne P; Swainey C; Hansen LA; Lyckholm L J Opioid Manag; 2006; 2(5):269-76. PubMed ID: 17319258 [TBL] [Abstract][Full Text] [Related]
13. Methadone for neuropathic pain: a new use for an old drug? Watson CP Can J Neurol Sci; 2005 Aug; 32(3):271-2. PubMed ID: 16225164 [No Abstract] [Full Text] [Related]
14. Transitioning a cancer patient from high-dose intravenous hydromorphone therapy to intravenous methadone. LeBaron V; Brody J; Lee EM; Hardin C; Snyder L J Pain Palliat Care Pharmacother; 2011; 25(4):356-61. PubMed ID: 22126165 [No Abstract] [Full Text] [Related]
15. Politics, cancer pain, and methadone. Baumrucker SJ Am J Hosp Palliat Care; 2000; 17(3):153-4. PubMed ID: 11886064 [No Abstract] [Full Text] [Related]
16. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study. Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781 [TBL] [Abstract][Full Text] [Related]